[
  {
    "title": "OK镜产品获医疗器械注册批准后，昊海生科能否逃逸带量采购的重力？",
    "href": "http://stock.jrj.com.cn/2022/12/29074237244965.shtml",
    "datetime": "2022-12-29 07:42:06",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：子公司角膜塑形用硬性透气接触镜产品获得医疗器械注册批准",
    "href": "http://stock.jrj.com.cn/2022/12/27163837240748.shtml",
    "datetime": "2022-12-27 16:38:19",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟使用不超8.7亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/12/19170837222817.shtml",
    "datetime": "2022-12-19 17:08:08",
    "code": "688366"
  },
  {
    "title": "眼科领域政策变动信息频传 爱博医疗与昊海生科或展开“遭遇战”",
    "href": "http://stock.jrj.com.cn/2022/11/15073237138882.shtml",
    "datetime": "2022-11-15 07:32:45",
    "code": "688366"
  },
  {
    "title": "港股异动丨昊海生科AH股齐升 Q3净利润环比大增",
    "href": "http://stock.jrj.com.cn/2022/10/31141837099431.shtml",
    "datetime": "2022-10-31 14:18:10",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：135.1万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/10/25140237081252.shtml",
    "datetime": "2022-10-25 14:02:27",
    "code": "688366"
  },
  {
    "title": "昊海生科净利降69%垫底“医美三剑客” 逾4亿商誉存减值风险股价一年跌74%",
    "href": "http://stock.jrj.com.cn/2022/09/02113736966613.shtml",
    "datetime": "2022-09-02 11:37:40",
    "code": "688366"
  },
  {
    "title": "昊海生科披露2022年半年报 实现营收9.68亿元",
    "href": "http://stock.jrj.com.cn/2022/08/29094036945751.shtml",
    "datetime": "2022-08-29 09:40:31",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)半年度净利润7103万元、同比下降69.25%",
    "href": "http://stock.jrj.com.cn/2022/08/26180436941725.shtml",
    "datetime": "2022-08-26 18:04:44",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)2021年度权益分派10派7元、股权登记日为8月8日",
    "href": "http://stock.jrj.com.cn/2022/08/01185136860243.shtml",
    "datetime": "2022-08-01 18:51:48",
    "code": "688366"
  },
  {
    "title": "昊海生科预计业绩大幅下降，2022年半年度盈利6500万至7800万元",
    "href": "http://stock.jrj.com.cn/2022/08/01114336858562.shtml",
    "datetime": "2022-08-01 11:43:11",
    "code": "688366"
  },
  {
    "title": "昊海生科：预计2022年半年度盈利6500万至7800万元 净利润同比下降71.86%至66.24%",
    "href": "http://stock.jrj.com.cn/2022/08/01101036858213.shtml",
    "datetime": "2022-08-01 10:10:30",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：利康瑞拟增资扩股实施员工持股计划",
    "href": "http://stock.jrj.com.cn/2022/07/31163336856583.shtml",
    "datetime": "2022-07-31 16:33:35",
    "code": "688366"
  },
  {
    "title": "昊海生科2022年上半年预计净利6500万-7800万同比减少66%-72% 毛利下降",
    "href": "http://stock.jrj.com.cn/2022/07/29231136855774.shtml",
    "datetime": "2022-07-29 23:11:35",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)半年度净利润预降66.24%-71.86%",
    "href": "http://stock.jrj.com.cn/2022/07/29170036854197.shtml",
    "datetime": "2022-07-29 17:00:50",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366)：调整2021年年度利润分配现金分红总额，每10股派发现金红利7元（含税）",
    "href": "http://stock.jrj.com.cn/2022/07/08093036793400.shtml",
    "datetime": "2022-07-08 09:30:00",
    "code": "688366"
  },
  {
    "title": "昊海生科：昊海发展拟将河北鑫视康60%股权转让于河北鑫梦达",
    "href": "http://stock.jrj.com.cn/2022/07/06141236786775.shtml",
    "datetime": "2022-07-06 14:12:01",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟以4160万元转让河北鑫视康60%股权",
    "href": "http://stock.jrj.com.cn/2022/07/05175536784136.shtml",
    "datetime": "2022-07-05 17:55:28",
    "code": "688366"
  },
  {
    "title": "昊海生科选举侯永泰为公司董事长 2021年公司净利3.52亿",
    "href": "http://stock.jrj.com.cn/2022/06/29221236769526.shtml",
    "datetime": "2022-06-29 22:12:58",
    "code": "688366"
  },
  {
    "title": "港股异动 | 昊海生科AH股齐涨 机构指其医美与眼科新品构建新增空间",
    "href": "http://stock.jrj.com.cn/2022/06/20145336742645.shtml",
    "datetime": "2022-06-20 14:53:58",
    "code": "688366"
  },
  {
    "title": "快讯：昊海生科急速拉升6.41% 主力资金净流入829.36万元(dev)",
    "href": "http://stock.jrj.com.cn/2022/06/17132136737518.shtml",
    "datetime": "2022-06-17 13:21:02",
    "code": "688366"
  },
  {
    "title": "昊海生科并购后遗症净利连降两季 遭明星基金抛售市值8个月蒸发330亿",
    "href": "http://stock.jrj.com.cn/2022/04/07102536267027.shtml",
    "datetime": "2022-04-07 10:25:45",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年净利3.52亿同比增长53.1% 董事长侯永泰薪酬133.5万",
    "href": "http://stock.jrj.com.cn/2022/03/29145236127861.shtml",
    "datetime": "2022-03-29 14:52:39",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：2021年净利增53.10%至3.52亿元 拟10派7元",
    "href": "http://stock.jrj.com.cn/2022/03/28193635921156.shtml",
    "datetime": "2022-03-28 19:36:10",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：向204名激励对象首次授予144万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/03/11190934815168.shtml",
    "datetime": "2022-03-11 19:09:43",
    "code": "688366"
  },
  {
    "title": "昊海生科各项业务恢复净利增53% 内生外延并举加速眼科医美布局",
    "href": "http://stock.jrj.com.cn/2022/03/01074534503257.shtml",
    "datetime": "2022-03-01 07:45:34",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年净利3.52亿同比增长53.19% 各类营销和市场活动恢复正常",
    "href": "http://stock.jrj.com.cn/2022/02/27211234489252.shtml",
    "datetime": "2022-02-27 21:12:38",
    "code": "688366"
  },
  {
    "title": "昊海生科：2021年归母净利同比增53.19%",
    "href": "http://stock.jrj.com.cn/2022/02/27195834489038.shtml",
    "datetime": "2022-02-27 19:58:10",
    "code": "688366"
  },
  {
    "title": "昊海生科、爱美客、迈瑞医疗强势反弹，医疗器械ETF（159883）大涨3.58％！",
    "href": "http://stock.jrj.com.cn/2022/02/25103834464008.shtml",
    "datetime": "2022-02-25 10:38:31",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年预计净利3.5亿-3.8亿同比增长52%-65% 主要产品国内市场需求增长",
    "href": "http://stock.jrj.com.cn/2022/01/28201034248450.shtml",
    "datetime": "2022-01-28 20:10:51",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：2021年度净利预增52.13%-65.17%",
    "href": "http://stock.jrj.com.cn/2022/01/28164334243100.shtml",
    "datetime": "2022-01-28 16:43:52",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：累计获得政府补助共2821.28万元",
    "href": "http://stock.jrj.com.cn/2022/01/12180334150660.shtml",
    "datetime": "2022-01-12 18:03:53",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：减持期过半 董事长侯永泰未实施减持",
    "href": "http://stock.jrj.com.cn/2022/01/11172934146613.shtml",
    "datetime": "2022-01-11 17:29:44",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：股东楼国梁完成减持79.14万股",
    "href": "http://stock.jrj.com.cn/2022/01/03160134109791.shtml",
    "datetime": "2022-01-03 16:01:50",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟推2021年A股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/12/29185134082354.shtml",
    "datetime": "2021-12-29 18:51:56",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：股东楼国梁拟减持不超79.15万股",
    "href": "http://stock.jrj.com.cn/2021/12/22173734047921.shtml",
    "datetime": "2021-12-22 17:37:38",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟使用不超9.8亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/12/20183434035556.shtml",
    "datetime": "2021-12-20 18:34:59",
    "code": "688366"
  },
  {
    "title": "昊海生科：子公司拟7000万元对价收购南鹏光学51%股权",
    "href": "http://stock.jrj.com.cn/2021/12/01201133951398.shtml",
    "datetime": "2021-12-01 20:11:28",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：子公司肝素表面处理非球面人工晶状体产品获得医疗器械注册批准",
    "href": "http://stock.jrj.com.cn/2021/11/30181133945114.shtml",
    "datetime": "2021-11-30 18:11:28",
    "code": "688366"
  },
  {
    "title": "昊海生科：股东变更股份减持计划，拟增加大宗交易减持方式",
    "href": "http://stock.jrj.com.cn/2021/11/22110533902854.shtml",
    "datetime": "2021-11-22 11:05:53",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：股东楼国梁变更股份减持计划",
    "href": "http://stock.jrj.com.cn/2021/11/19180833881043.shtml",
    "datetime": "2021-11-19 18:08:37",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：核心技术人员Timothy Higgs离职",
    "href": "http://stock.jrj.com.cn/2021/11/17173733866894.shtml",
    "datetime": "2021-11-17 17:37:24",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：子公司预装式非球面人工晶状体产品获得医疗器械注册批准",
    "href": "http://stock.jrj.com.cn/2021/11/01173333798704.shtml",
    "datetime": "2021-11-01 17:33:39",
    "code": "688366"
  },
  {
    "title": "昊海生科：预装式非球面人工晶状体产品获得医疗器械注册批准",
    "href": "http://stock.jrj.com.cn/2021/11/01172633798661.shtml",
    "datetime": "2021-11-01 17:26:33",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：第三季度净利润降6.63%至7947.22万元",
    "href": "http://stock.jrj.com.cn/2021/10/28213233772538.shtml",
    "datetime": "2021-10-28 21:32:47",
    "code": "688366"
  },
  {
    "title": "昊海生科前三季度营业收入12.75亿元，同比增长42.89%",
    "href": "http://stock.jrj.com.cn/2021/10/28193533771495.shtml",
    "datetime": "2021-10-28 19:35:25",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：67.24万股限售股将于11月1日解禁上市",
    "href": "http://stock.jrj.com.cn/2021/10/22181733734637.shtml",
    "datetime": "2021-10-22 18:17:50",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：前三季度净利预增166.32%至192.95%",
    "href": "http://stock.jrj.com.cn/2021/10/15183633699631.shtml",
    "datetime": "2021-10-15 18:36:36",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：股东楼国梁累计减持81.35万股 减持计划尚未实施完毕",
    "href": "http://stock.jrj.com.cn/2021/09/21165633487138.shtml",
    "datetime": "2021-09-21 16:56:25",
    "code": "688366"
  },
  {
    "title": "昊海生科：因自身资金需要 董事长侯永泰拟减持不超0.3697%股份",
    "href": "http://stock.jrj.com.cn/2021/09/10201933417010.shtml",
    "datetime": "2021-09-10 20:19:09",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：董事长侯永泰拟减持不超65万股",
    "href": "http://stock.jrj.com.cn/2021/09/10174633416000.shtml",
    "datetime": "2021-09-10 17:46:43",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年半年度净利2.31亿元 同比净利增加739.25%",
    "href": "http://stock.jrj.com.cn/2021/08/26185933325863.shtml",
    "datetime": "2021-08-26 18:59:55",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)半年度净利润2.31亿元 同比增长739.25%",
    "href": "http://stock.jrj.com.cn/2021/08/26182833325598.shtml",
    "datetime": "2021-08-26 18:28:29",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)2020年度权益分派10派5元 股权登记日为7月28日",
    "href": "http://stock.jrj.com.cn/2021/07/21174733130655.shtml",
    "datetime": "2021-07-21 17:47:45",
    "code": "688366"
  },
  {
    "title": "CXO、医美板块逆市走强，昊海生科涨近6%，医疗ETF（512170）放量拉涨2.5%",
    "href": "http://stock.jrj.com.cn/2021/07/14101833093588.shtml",
    "datetime": "2021-07-14 10:18:19",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：股东楼国梁持股比例下降到5%以下",
    "href": "http://stock.jrj.com.cn/2021/07/06213933054704.shtml",
    "datetime": "2021-07-06 21:39:30",
    "code": "688366"
  },
  {
    "title": "颜值经济汹涌，爱美客、华熙生物、昊海生科集体走高，颜值担当医疗器械ETF大涨1.79%创上市新高！",
    "href": "http://stock.jrj.com.cn/2021/07/01111133026681.shtml",
    "datetime": "2021-07-01 11:11:33",
    "code": "688366"
  },
  {
    "title": "医美逆市暴走！爱美客、昊海生科、华熙生物股价齐创新高，银河证券：医美时代乘势而至",
    "href": "http://stock.jrj.com.cn/2021/07/01102833026478.shtml",
    "datetime": "2021-07-01 10:28:00",
    "code": "688366"
  },
  {
    "title": "医美概念股走强 昊海生科创历史新高",
    "href": "http://stock.jrj.com.cn/2021/07/01095833026329.shtml",
    "datetime": "2021-07-01 09:58:25",
    "code": "688366"
  },
  {
    "title": "昊海生科20%涨停！核酸检测概念拉升医疗ETF（512170）再创新高",
    "href": "http://stock.jrj.com.cn/2021/06/28104333008908.shtml",
    "datetime": "2021-06-28 10:43:37",
    "code": "688366"
  },
  {
    "title": "A股异动 | 昊海生科(688366.SH)涨停 料上半年净利润同比增长699%-808%",
    "href": "http://stock.jrj.com.cn/2021/06/28093633008491.shtml",
    "datetime": "2021-06-28 09:36:08",
    "code": "688366"
  },
  {
    "title": "昊海生科预计上半年净利润同比增长699%至808%",
    "href": "http://stock.jrj.com.cn/2021/06/26071032999731.shtml",
    "datetime": "2021-06-26 07:10:00",
    "code": "688366"
  },
  {
    "title": "昊海生科预计上半年净利润同比增长699%至808%",
    "href": "http://stock.jrj.com.cn/2021/06/26071033102043.shtml",
    "datetime": "2021-06-26 07:10:00",
    "code": "688366"
  },
  {
    "title": "【公告抢先看】晚间公告：亿华通拟以简易程序定增募资不超过2亿元、昊海生科上半年净利预增699%-808%",
    "href": "http://stock.jrj.com.cn/2021/06/25181232997466.shtml",
    "datetime": "2021-06-25 18:12:37",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)半年度净利润预增699.21%至808.19%",
    "href": "http://stock.jrj.com.cn/2021/06/25180932997451.shtml",
    "datetime": "2021-06-25 18:09:39",
    "code": "688366"
  },
  {
    "title": "昊海生科：昊海生科旗下已有三款玻尿酸产品获得III类医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/06/24105032988258.shtml",
    "datetime": "2021-06-24 10:50:46",
    "code": "688366"
  },
  {
    "title": "昊海生科：股东楼国梁因违规减持致歉",
    "href": "http://stock.jrj.com.cn/2021/06/23111332981537.shtml",
    "datetime": "2021-06-23 11:13:40",
    "code": "688366"
  },
  {
    "title": "A股异动 | 昊海生科(688366.SH)跌4% 股东楼国梁拟减持不超216.5万股",
    "href": "http://stock.jrj.com.cn/2021/06/02093932861455.shtml",
    "datetime": "2021-06-02 09:39:56",
    "code": "688366"
  },
  {
    "title": "昊海生科：持股5%以上股东楼国梁因自身资金需要 拟减持不超216.50万股公司股份",
    "href": "http://stock.jrj.com.cn/2021/06/01204832859172.shtml",
    "datetime": "2021-06-01 20:48:14",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：持股5.26%股东楼国梁拟减持不超216.5万股",
    "href": "http://stock.jrj.com.cn/2021/06/01181232858152.shtml",
    "datetime": "2021-06-01 18:12:06",
    "code": "688366"
  },
  {
    "title": "【年中调仓季】集齐医美三剑客爱美客、华熙生物和昊海生科，医疗器械ETF（159883）或成A股“颜值”担当",
    "href": "http://stock.jrj.com.cn/2021/05/31092032847326.shtml",
    "datetime": "2021-05-31 09:20:52",
    "code": "688366"
  },
  {
    "title": "医美板块走强 昊海生科(688366.SH)涨超8%",
    "href": "http://stock.jrj.com.cn/2021/05/27134432828950.shtml",
    "datetime": "2021-05-27 13:44:00",
    "code": "688366"
  },
  {
    "title": "上市后对外投资是否投向科创领域？昊海生科回复年报问询函",
    "href": "http://stock.jrj.com.cn/2021/05/17101832767968.shtml",
    "datetime": "2021-05-17 10:18:25",
    "code": "688366"
  },
  {
    "title": "港股异动丨昊海生科涨近4% 一季度业绩扭亏为盈至9699.27万元",
    "href": "http://stock.jrj.com.cn/2021/04/26102132452326.shtml",
    "datetime": "2021-04-26 10:21:11",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年第一季度净利9699.27万 各项业务均已全面恢复",
    "href": "http://stock.jrj.com.cn/2021/04/24195632435688.shtml",
    "datetime": "2021-04-24 19:56:19",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)一季度业绩扭亏为盈至9699.27万元",
    "href": "http://stock.jrj.com.cn/2021/04/23171132430725.shtml",
    "datetime": "2021-04-23 17:11:01",
    "code": "688366"
  },
  {
    "title": "昊海生科扣非净利暴跌超40% “医美三剑客”掉队者靠收购能否逆袭",
    "href": "http://stock.jrj.com.cn/2021/04/15071132376543.shtml",
    "datetime": "2021-04-15 07:11:53",
    "code": "688366"
  },
  {
    "title": "去年营利创近四年新低，医美三剑客之一的昊海生科怎么了？",
    "href": "http://stock.jrj.com.cn/2021/04/12173132358439.shtml",
    "datetime": "2021-04-12 17:31:27",
    "code": "688366"
  },
  {
    "title": "昊海生科：赛美视生物产品获得欧盟CE认证证书",
    "href": "http://stock.jrj.com.cn/2021/04/12133432357247.shtml",
    "datetime": "2021-04-12 13:34:52",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：模注成型、散光人工晶状体产品获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/04/09170632342953.shtml",
    "datetime": "2021-04-09 17:06:14",
    "code": "688366"
  },
  {
    "title": "昊海生科：上海利康瑞获得猪纤维蛋白粘合剂药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/02101332269117.shtml",
    "datetime": "2021-04-02 10:13:01",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：全资子公司获猪纤维蛋白粘合剂药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/04/01183032264244.shtml",
    "datetime": "2021-04-01 18:30:00",
    "code": "688366"
  },
  {
    "title": "昊海生科2021年一季度净利预计8000万-1亿：销售收入大幅增长",
    "href": "http://stock.jrj.com.cn/2021/03/27090932226772.shtml",
    "datetime": "2021-03-27 09:09:53",
    "code": "688366"
  },
  {
    "title": "昊海生科2020年净利2.3亿下滑37.95%：董事长侯永泰薪酬115万",
    "href": "http://stock.jrj.com.cn/2021/03/27090932226767.shtml",
    "datetime": "2021-03-27 09:09:17",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：2021年一季度扭亏为盈 预盈8000万元-1亿元",
    "href": "http://stock.jrj.com.cn/2021/03/26214732224735.shtml",
    "datetime": "2021-03-26 21:47:59",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)2020年度净利润降37.95%至2.3亿元 拟10派5元",
    "href": "http://stock.jrj.com.cn/2021/03/26191632224024.shtml",
    "datetime": "2021-03-26 19:16:07",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟取得亨泰视觉55%股权并取得并取得亨泰光学角膜塑形镜产品myOK独家经销权",
    "href": "http://stock.jrj.com.cn/2021/03/19183832165374.shtml",
    "datetime": "2021-03-19 18:38:21",
    "code": "688366"
  },
  {
    "title": "A股异动 | 昊海生科(688366.SH)涨超5% 盐酸莫西沙星滴眼液获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/11145932109248.shtml",
    "datetime": "2021-03-11 14:59:09",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：盐酸莫西沙星滴眼液获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/10185732104952.shtml",
    "datetime": "2021-03-10 18:57:48",
    "code": "688366"
  },
  {
    "title": "说明目标公司整体估值较其账面净资产增值率高的原因 昊海生科回复监管工作函",
    "href": "http://stock.jrj.com.cn/2021/03/10104032102439.shtml",
    "datetime": "2021-03-10 10:40:00",
    "code": "688366"
  },
  {
    "title": "昊海生科收监管工作函 营收净利双降股价已连跌3日",
    "href": "http://stock.jrj.com.cn/2021/03/01140232049560.shtml",
    "datetime": "2021-03-01 14:02:00",
    "code": "688366"
  },
  {
    "title": "昊海生科2020年度净利2.3亿下滑37.95% 各项经营费用支出维持相对高位",
    "href": "http://stock.jrj.com.cn/2021/02/25200032027575.shtml",
    "datetime": "2021-02-25 20:00:39",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)业绩快报：2020年度净利降37.95%至2.3亿元",
    "href": "http://stock.jrj.com.cn/2021/02/25171932026260.shtml",
    "datetime": "2021-02-25 17:19:02",
    "code": "688366"
  },
  {
    "title": "昊海生科2亿并购加码医美 上市业绩变脸销售费占超50%",
    "href": "http://stock.jrj.com.cn/2021/02/23071332009894.shtml",
    "datetime": "2021-02-23 07:13:22",
    "code": "688366"
  },
  {
    "title": "业务由“医疗端”向“消费端”扩展，昊海生科将获欧华美科63.64%股权",
    "href": "http://stock.jrj.com.cn/2021/02/22103332004419.shtml",
    "datetime": "2021-02-22 10:33:22",
    "code": "688366"
  },
  {
    "title": "A股异动 | 昊海生科(688366.SH)涨超11% 拟收购欧华美科63.64%股权",
    "href": "http://stock.jrj.com.cn/2021/02/22095732004034.shtml",
    "datetime": "2021-02-22 09:57:35",
    "code": "688366"
  },
  {
    "title": "昊海生科1.35亿元收购股权、对外投资",
    "href": "http://stock.jrj.com.cn/invest/2021/02/22081832091280.shtml",
    "datetime": "2021-02-22 08:18:00",
    "code": "688366"
  },
  {
    "title": "“必须涨停板！”公告加码医美业务，这家公司的股吧沸腾了",
    "href": "http://stock.jrj.com.cn/2021/02/22080632003501.shtml",
    "datetime": "2021-02-22 08:06:55",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟以共2.05亿元获得欧华美科63.64%的股权",
    "href": "http://stock.jrj.com.cn/2021/02/21192231999702.shtml",
    "datetime": "2021-02-21 19:22:26",
    "code": "688366"
  },
  {
    "title": "昊海生科：子公司模注成型、疏水性人工晶状体产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/02/02092631834655.shtml",
    "datetime": "2021-02-02 09:26:26",
    "code": "688366"
  },
  {
    "title": "[昊海生科]昊海生科被纳入沪港通!2月1日生效!",
    "href": "http://stock.jrj.com.cn/2021/01/27000031790823.shtml",
    "datetime": "2021-01-27 00:00:00",
    "code": "688366"
  },
  {
    "title": "昊海生科(688366.SH)：拟使用最高不超10.56亿元暂时闲置资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2020/12/28194231588000.shtml",
    "datetime": "2020-12-28 19:42:41",
    "code": "688366"
  },
  {
    "title": "昊海生科被错杀了吗？|品质公司",
    "href": "http://stock.jrj.com.cn/2020/12/23081031550039.shtml",
    "datetime": "2020-12-23 08:10:40",
    "code": "688366"
  },
  {
    "title": "[昊海生科]只需几分钟,依镜PRL助力首位百人明眸公益行动受益者摆脱“啤酒瓶底”",
    "href": "http://stock.jrj.com.cn/2020/11/14000031291153.shtml",
    "datetime": "2020-11-14 00:00:00",
    "code": "688366"
  },
  {
    "title": "昊海生科：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/28001031145367.shtml",
    "datetime": "2020-10-28 00:10:12",
    "code": "688366"
  },
  {
    "title": "昊海生科前三季度净利1.13亿减少55.13% 信用减值损失增加",
    "href": "http://stock.jrj.com.cn/2020/10/27192731143779.shtml",
    "datetime": "2020-10-27 19:27:38",
    "code": "688366"
  },
  {
    "title": "昊海生科：首次公开发行部分限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/10/24001031119680.shtml",
    "datetime": "2020-10-24 00:10:19",
    "code": "688366"
  },
  {
    "title": "昊海生科：公司具备玻尿酸产品从上游原料到终端制剂的全产业链研发、生产和销售能力",
    "href": "http://stock.jrj.com.cn/2020/10/13171431044400.shtml",
    "datetime": "2020-10-13 17:14:47",
    "code": "688366"
  },
  {
    "title": "上市不到一年扣非净利下降96% 昊海生科逆市推高端产品之谜",
    "href": "http://stock.jrj.com.cn/2020/09/30074730864806.shtml",
    "datetime": "2020-09-30 07:47:51",
    "code": "688366"
  },
  {
    "title": "昊海生科：公司账面留存了较多的现金类资产 资产负债率也很低 导致公司的总资产周转率和权益乘数偏低",
    "href": "http://stock.jrj.com.cn/2020/09/14220230750043.shtml",
    "datetime": "2020-09-14 22:02:40",
    "code": "688366"
  },
  {
    "title": "昊海生科上半年扣非净利降96% 瑞银证券保荐上科创板",
    "href": "http://stock.jrj.com.cn/2020/08/28162830614678.shtml",
    "datetime": "2020-08-28 16:28:00",
    "code": "688366"
  },
  {
    "title": "昊海生科2020年上半年净利2752.72万下滑84.92% 费用支出维持高位",
    "href": "http://stock.jrj.com.cn/2020/08/28144030614004.shtml",
    "datetime": "2020-08-28 14:40:06",
    "code": "688366"
  },
  {
    "title": "昊海生科2020年上半年净利2753万减少85% 产品销售收入同比下降",
    "href": "http://stock.jrj.com.cn/2020/08/17104330516270.shtml",
    "datetime": "2020-08-17 10:43:53",
    "code": "688366"
  },
  {
    "title": "A股“新生”昊海生科净利润预减超九成 玻尿酸不好卖 业绩回升无期",
    "href": "http://stock.jrj.com.cn/2020/08/17081430515485.shtml",
    "datetime": "2020-08-17 08:14:00",
    "code": "688366"
  },
  {
    "title": "A股“新生”昊海生科净利润预减超九成 玻尿酸不好卖 业绩回升无期",
    "href": "http://stock.jrj.com.cn/2020/08/17081430541686.shtml",
    "datetime": "2020-08-17 08:14:00",
    "code": "688366"
  },
  {
    "title": "昊海生科放量涨停 公司提示风险",
    "href": "http://stock.jrj.com.cn/2020/08/04185430425343.shtml",
    "datetime": "2020-08-04 18:54:18",
    "code": "688366"
  },
  {
    "title": "昊海生科及子公司自2019年7月1日以来获得政府补助4744.86万元",
    "href": "http://stock.jrj.com.cn/2020/05/03120929494462.shtml",
    "datetime": "2020-05-03 12:09:05",
    "code": "688366"
  },
  {
    "title": "昊海生科2020年一季度亏损2485.54万元 同比由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/30223129435535.shtml",
    "datetime": "2020-04-30 22:31:47",
    "code": "688366"
  },
  {
    "title": "昊海生科：首次公开发行网下配售限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/04/23013029352732.shtml",
    "datetime": "2020-04-23 01:30:01",
    "code": "688366"
  },
  {
    "title": "昊海生科：控股杭州爱晶伦加速眼科产业链布局",
    "href": "http://stock.jrj.com.cn/2020/04/22180929350423.shtml",
    "datetime": "2020-04-22 18:09:34",
    "code": "688366"
  },
  {
    "title": "科创板首份年报问询函出炉 昊海生科对外投资被重点关注",
    "href": "http://stock.jrj.com.cn/2020/04/15130929294964.shtml",
    "datetime": "2020-04-15 13:09:05",
    "code": "688366"
  },
  {
    "title": "昊海生科回复上交所问询 详解数项对外投资来龙去脉",
    "href": "http://stock.jrj.com.cn/2020/04/15110829294333.shtml",
    "datetime": "2020-04-15 11:08:00",
    "code": "688366"
  },
  {
    "title": "昊海生科：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/03/27012029122033.shtml",
    "datetime": "2020-03-27 01:20:04",
    "code": "688366"
  },
  {
    "title": "昊海生科：第四届董事会第十四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/27012029121969.shtml",
    "datetime": "2020-03-27 01:20:00",
    "code": "688366"
  },
  {
    "title": "昊海生科2019年净利润3.71亿元 拟现金分红1.24亿元",
    "href": "http://stock.jrj.com.cn/2020/03/26194729120315.shtml",
    "datetime": "2020-03-26 19:47:00",
    "code": "688366"
  },
  {
    "title": "昊海生科：2019年净利同比降10.56% 拟10派7元",
    "href": "http://stock.jrj.com.cn/2020/03/26190029120078.shtml",
    "datetime": "2020-03-26 19:00:00",
    "code": "688366"
  },
  {
    "title": "昊海生科：2019年净利同比下降11% 拟10派7元",
    "href": "http://stock.jrj.com.cn/2020/03/26184429119941.shtml",
    "datetime": "2020-03-26 18:44:29",
    "code": "688366"
  },
  {
    "title": "昊海生科2019年净利3.7亿下滑11% 玻尿酸产品销售收入有所下降",
    "href": "http://stock.jrj.com.cn/2020/02/28100528911912.shtml",
    "datetime": "2020-02-28 10:05:48",
    "code": "688366"
  },
  {
    "title": "昊海生科2019年业绩快报：眼科、医美研发投入持续“加码”",
    "href": "http://stock.jrj.com.cn/2020/02/27220028909186.shtml",
    "datetime": "2020-02-27 22:00:53",
    "code": "688366"
  },
  {
    "title": "昊海生科：2020年第一次临时股东大会、2020年第一次A股类别股东大会及2020年第一次H股类别股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/02/14213028831559.shtml",
    "datetime": "2020-02-14 21:30:02",
    "code": "688366"
  },
  {
    "title": "昊海生科：公司在积极研发新型的玻尿酸产品",
    "href": "http://stock.jrj.com.cn/2019/11/29165728469007.shtml",
    "datetime": "2019-11-29 16:57:00",
    "code": "688366"
  },
  {
    "title": "科创板过会企业“满百” 改革乘数效应优化生态",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/27021828454881.shtml",
    "datetime": "2019-11-27 02:18:47",
    "code": "688366"
  },
  {
    "title": "科创板首例破发新股昊海生科背后:股价向上 盈利向下",
    "href": "http://stock.jrj.com.cn/2019/11/06201628361748.shtml",
    "datetime": "2019-11-06 20:16:36",
    "code": "688366"
  },
  {
    "title": "昊海生科成首支破发的科创板个股 公司：有稳定股价承诺",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/06151728360074.shtml",
    "datetime": "2019-11-06 15:17:23",
    "code": "688366"
  },
  {
    "title": "科创板昊海生科跌破发行价 公司：有稳定股价承诺",
    "href": "http://stock.jrj.com.cn/2019/11/06132828359332.shtml",
    "datetime": "2019-11-06 13:28:00",
    "code": "688366"
  },
  {
    "title": "科创板两股盘中破发！昊海生科：有稳定股价承诺",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/06130928359251.shtml",
    "datetime": "2019-11-06 13:09:50",
    "code": "688366"
  },
  {
    "title": "科创板首例！久日新材、昊海生科盘中双双破发",
    "href": "http://stock.jrj.com.cn/kcb/2019/11/06105428358816.shtml",
    "datetime": "2019-11-06 10:54:35",
    "code": "688366"
  },
  {
    "title": "久日新材、昊海生科2家科创板公司破发 前者仅上市2天",
    "href": "http://stock.jrj.com.cn/2019/11/06094628358090.shtml",
    "datetime": "2019-11-06 09:46:46",
    "code": "688366"
  },
  {
    "title": "科创板昊海生科跌破发行价",
    "href": "http://stock.jrj.com.cn/2019/11/06093228358006.shtml",
    "datetime": "2019-11-06 09:32:00",
    "code": "688366"
  },
  {
    "title": "科创板首例！昊海生科上市第六日盘中破发",
    "href": "http://stock.jrj.com.cn/2019/11/06093028357966.shtml",
    "datetime": "2019-11-06 09:30:51",
    "code": "688366"
  },
  {
    "title": "昊海生科今日上市 发行价格89.23元/股",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/30085428342481.shtml",
    "datetime": "2019-10-30 08:54:22",
    "code": "688366"
  },
  {
    "title": "10月30日新股提示：广电计量、筑博设计、八方股份申购 赛诺医疗、昊海生科上市",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/30085428342492.shtml",
    "datetime": "2019-10-30 08:54:21",
    "code": "688366"
  },
  {
    "title": "昊海生科中签号出炉 共12254个",
    "href": "http://stock.jrj.com.cn/2019/10/22191828284152.shtml",
    "datetime": "2019-10-22 19:18:00",
    "code": "688366"
  },
  {
    "title": "【兑奖啦】科创板致远互联、昊海生科网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/22190828284092.shtml",
    "datetime": "2019-10-22 19:08:23",
    "code": "688366"
  },
  {
    "title": "【兑奖啦】科创板昊海生科网上申购中签号出炉 共12254个",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/22190528284081.shtml",
    "datetime": "2019-10-22 19:05:19",
    "code": "688366"
  },
  {
    "title": "昊海生科、致远互联网上发行中签率出炉",
    "href": "http://stock.jrj.com.cn/ipo/2019/10/21212728278716.shtml",
    "datetime": "2019-10-21 21:27:28",
    "code": "688366"
  },
  {
    "title": "科创板昊海生科：网上发行中签率为0.0413%",
    "href": "http://stock.jrj.com.cn/2019/10/21193428278599.shtml",
    "datetime": "2019-10-21 19:34:00",
    "code": "688366"
  },
  {
    "title": "新股提示：致远互联、昊海生科今日申购",
    "href": "http://stock.jrj.com.cn/2019/10/21075328274694.shtml",
    "datetime": "2019-10-21 07:53:00",
    "code": "688366"
  },
  {
    "title": "申购倍数高达635倍 首家“H+科创板”企业昊海生科定价89.23元/股",
    "href": "http://stock.jrj.com.cn/kcb/2019/10/21013128272831.shtml",
    "datetime": "2019-10-21 01:31:51",
    "code": "688366"
  },
  {
    "title": "昊海生科发行价为每股89.23元 刷新科创板纪录",
    "href": "http://stock.jrj.com.cn/2019/10/18162428267992.shtml",
    "datetime": "2019-10-18 16:24:46",
    "code": "688366"
  },
  {
    "title": "科创板新股致远互联、昊海生科10月21日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2019/10/18141428267089.shtml",
    "datetime": "2019-10-18 14:14:15",
    "code": "688366"
  },
  {
    "title": "A股头条：中美双方正在加紧磋商 英国与欧盟达成脱欧协议",
    "href": "http://stock.jrj.com.cn/2019/10/18051628264278.shtml",
    "datetime": "2019-10-18 05:16:13",
    "code": "688366"
  },
  {
    "title": "昊海生科、致远互联确定发行价 10月21日网上申购",
    "href": "http://stock.jrj.com.cn/2019/10/17234728264130.shtml",
    "datetime": "2019-10-17 23:47:00",
    "code": "688366"
  },
  {
    "title": "89.23元/股！昊海生科发行价为目前科创板最高",
    "href": "http://stock.jrj.com.cn/kcb/2019/10/17214028263440.shtml",
    "datetime": "2019-10-17 21:40:18",
    "code": "688366"
  },
  {
    "title": "证监会同意昊海生科、赛诺医疗科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2019/09/27210728193403.shtml",
    "datetime": "2019-09-27 21:07:00",
    "code": "688366"
  },
  {
    "title": "科创板拟上市公司昊海生科提交注册",
    "href": "http://stock.jrj.com.cn/2019/07/23170827877253.shtml",
    "datetime": "2019-07-23 17:08:00",
    "code": "688366"
  },
  {
    "title": "科创板天奈科技、昊海生科首发申请获通过",
    "href": "http://stock.jrj.com.cn/2019/07/15170827842622.shtml",
    "datetime": "2019-07-15 17:08:00",
    "code": "688366"
  },
  {
    "title": "科创板拟上市企业昊海生科披露招股书上会稿",
    "href": "http://stock.jrj.com.cn/2019/07/04224727798811.shtml",
    "datetime": "2019-07-04 22:47:00",
    "code": "688366"
  },
  {
    "title": "科创板拟上市企业华熙生物、昊海生科回复三轮问询",
    "href": "http://stock.jrj.com.cn/2019/06/04180427663408.shtml",
    "datetime": "2019-06-04 18:04:00",
    "code": "688366"
  },
  {
    "title": "与华熙生物亦敌亦友 昊海生科专注买买买持续竞争力待考",
    "href": "http://stock.jrj.com.cn/2019/05/21150727601445.shtml",
    "datetime": "2019-05-21 15:07:46",
    "code": "688366"
  }
]